Malaria Vaccines Market – Paving the Way for a Malaria-free World | Show Rapid Growth Until 2027 Explore By GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.

The leading research firm Coherent Market Insights published a research report on "Malaria Vaccines Market Size Analysis and Forecast 2026" which serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts, about the Malaria Vaccines Market. The whole information from scratch to the financial and management level of the established industries associated with the Malaria Vaccines Market at the global level is initially acquired by the dedicated team. The gathered data involves the information about the industry’s establishment, market Size, Share, type and the form of products it manufactures, annual sales and revenue generation, the demand of the manufactured product in the market, marketing trends followed by the industry, and a lot more important information.

Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased inclination of various healthcare agencies towards addressing this major malady. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working towards developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the 90% of malaria cases and hence, this region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study.

Get Quick access to Report Sample @ https://www.coherentmarketinsights.com/insight/request-sample/37

People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future.

The global malaria vaccines market is expected to be valued at US$ 50.6 million in 2024 and is expected to witness a CAGR of 150.0% during the forecast period (2024 – 2027).

Tremendous potential in the malaria vaccines market

Potential for malaria vaccines is estimated to be huge as a large share of population, 90%-95%, at risk of infection in Africa and South East-Asia. Advent of vaccines for adult population, would be a major breakthrough for the malaria vaccines market. Below are certain alarming statistics that embarks the need for a malaria vaccine:

• Artemisinin resistance has been detected in five countries – Laos, Cambodia, Myanmar, Vietnam and Thailand
• Resistance to P. falciparum parasite against the most available anti-malarial medicines is being reported
• According to the National Vector Borne Disease Control Programme, nearly 95% of the population in India reside in malaria endemic areas
• There were 216 million malaria cases globally in 2016 (WHO)
• Africa is the most affected region with 90% of malaria cases and deaths worldwide (WHO)
• Pregnant women, children below 5 years of age, and tourists from countries with low incidence rate of malaria are identified as the most susceptible target population for malaria

The global malaria vaccines market is expected to experience a huge trajectory growth with the launch of first malarial vaccine in near future.

Increasing accessibility and government support to contribute towards the malaria vaccines market growth

The WHO has established a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with certain defined goals, one of them aimed at eliminating malaria in at least 10 countries. Similarly, the Indian government has established Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance by various government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Support from such national and global initiatives will drive malaria vaccines market growth during the forecast period.

Many such non-profit organizations and pharmaceutical companies are conducting research on malaria vaccines. Approximately 31 trials are under progress for malaria vaccine development with a few being blood stage projects. Availability of funds and government support programs will encourage commercialization of product with successful trial results, thus boosting the malaria vaccines market growth trajectory.

Grab Your Report at an Impressive Discount @ https://www.coherentmarketinsights.com/insight/request-discount/37

Reasons to Buy:

• Establish comprehensive understanding of the pipeline activity across this Malaria Vaccines to formulate effective R&D strategies

• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Malaria Vaccines therapeutics

• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Some Important TOC:

• Market Overview
• Global Malaria Vaccines Market Landscape by Player
• Players Profiles
• Global Production, Revenue (Value), Price Trend by Type
• Market Analysis by Application
• Global Malaria Vaccines Production, Consumption, Export, Import by Region (2013-2018)
• Production, Revenue (Value) by Region (2013-2018)
• Malaria Vaccines Manufacturing Analysis
• Industrial Chain, Sourcing Strategy and Downstream Buyers
• Market Dynamics
• Global Malaria Vaccines Market Forecast (2018-2026)
• Research Findings and Conclusion
• Appendix

To Conversation With Our Analysts Click @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/37

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.